News Coverage | Parker Institute for Cancer Immunotherapy

STAT News

01.14.20

Innovation in biotech R&D: New resources offer new hope

Read

Endpoints

12.24.19

The top 10 most popular Endpoints News pieces of 2019 — going viral is a whole new game in biopharma now

Read

Genetic Engineering & Biotechnology News

12.02.19

Top 10 Immuno-Oncology Startups of 2019

Read

Medscape

11.25.19

Harnessing the Power of Microbes to Fight Cancer

Read

HemOnc Today

11.25.19

UCLA Opens Clinical Trial of Bispecific CAR T-cell Therapy for Advanced Lymphoma, Leukemia

Read

Inside Philanthropy

11.25.19

Status Update: How Facebook’s Billionaires Are Changing the World of Philanthropy

Read

FierceBiotech

11.25.19

Could this immuno-oncology combo treat metastatic prostate cancer?

Read

The Conversation

11.25.19

How gene-edited white blood cells are helping fight cancer

Read

Myeloma Research News

11.13.19

CRISPR-edited T-cells Safely, Effectively Target Cancer Cells in Myeloma Patients, Early Phase 1 Data Suggests

Read

FierceBiotech

11.07.19

ASH: UPenn’s CRISPR-edited immune cells prove safe in small cancer study

Read

NPR

11.06.19

CRISPR Approach To Fighting Cancer Called ‘Promising’ In 1st Safety Test

Read

TMunity Therapeutics

11.06.19

Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach

Read